U.S. Water Utilities Stock News

NYSE:MC
NYSE:MCCapital Markets

Moelis (MC) Boosts Earnings and Buybacks Amid Rising Costs Is Its Capital Strategy Evolving?

In the past quarter, Moelis & Company reported fourth-quarter 2025 adjusted earnings of US$1.13 per share, with total revenues rising 11% year over year while higher compensation and non-compensation expenses lifted overall operating costs. The firm also repurchased 700,000 shares during the period, highlighting an active approach to capital allocation even as expenses increased. Next, we’ll examine how Moelis’s better‑than‑expected earnings and revenue, alongside rising operating costs,...
NasdaqGS:POWL
NasdaqGS:POWLElectrical

A Look At Powell Industries (POWL) Valuation After A Powerful Multi Year Share Price Run

What recent performance says about Powell Industries today Powell Industries (POWL) has drawn fresh attention after a strong past 3 months, with total return around 41%, following a much larger 1 year total return near 198%. For investors looking at the current setup, the stock last closed at US$483.65, with value metrics that some data providers group into a relatively low value score of 2. See our latest analysis for Powell Industries. That recent pullback in the share price, with a 7 day...
NasdaqGS:WYNN
NasdaqGS:WYNNHospitality

Can Wynn (WYNN) Turn UAE Geopolitical Risk Into a Long-Term Luxury Brand Advantage?

In recent weeks, Wynn Resorts has been closely monitoring escalating Middle East tensions after Iranian strikes near Dubai, where it is helping develop the US$5.10 billion Wynn Al Marjan Island resort in the UAE, while rolling out contingency measures to protect project staff and confirm the property’s planned 2027 opening. At the same time, Wynn has advanced its broader growth plans and brand positioning, from deepening its premium UAE commitment to launching an exclusive Zero Bond members’...
NasdaqGS:ADUS
NasdaqGS:ADUSHealthcare

A Look At Addus HomeCare (ADUS) Valuation After Strong Earnings And Acquisition-Fueled Growth

Addus HomeCare (ADUS) has drawn fresh attention after reporting fourth quarter net income of US$29.78 million and full year net income of US$95.91 million, together with higher diluted earnings per share from continuing operations. See our latest analysis for Addus HomeCare. Despite the stronger earnings story, recent share price momentum has been soft. The 90 day share price return shows an 8.82% decline, contrasting with a 1 year total shareholder return of 6.37%, suggesting interest has...
NasdaqGS:PAA
NasdaqGS:PAAOil and Gas

Plains All American Credit Moves Reshape Valuation And Investor Trade Offs

Plains All American Pipeline (NasdaqGS:PAA) reported a new definitive agreement in a recent SEC Form 8-K filing. The company also disclosed amendments to existing credit agreements with a group of major lenders. These updates relate to Plains All American Pipeline's financing structure and contractual commitments. Plains All American Pipeline focuses on the transportation, storage, and marketing of crude oil and related products, which ties its business closely to broader midstream energy...
NasdaqGS:NVAX
NasdaqGS:NVAXBiotechs

How Investors Are Reacting To Novavax (NVAX) Swinging From Losses To Profits On Vaccine Revenue

Novavax, Inc. recently reported fourth-quarter 2025 revenue of US$147.14 million and net income of US$17.53 million, alongside full-year 2025 revenue of US$1.12 billion and net income of US$440.30 million, marking a move from losses to profits versus the prior year. The shift from a prior-year full-year net loss of US$187.50 million to net income of US$440.30 million highlights how higher vaccine-related revenues and cost discipline have materially changed Novavax’s recent financial...
NYSE:KEY
NYSE:KEYBanks

Is It Time To Reconsider KeyCorp (KEY) After Its Recent Share Price Pullback?

If you are wondering whether KeyCorp is attractively priced or already fully valued, you are not alone. This article is designed to help you make sense of where it stands today. KeyCorp shares last closed at US$19.86, with returns of a 4.2% decline over 7 days, a 12.3% decline over 30 days, a 5.3% decline year to date, but a 32% gain over 1 year, 49.6% over 3 years and 18.7% over 5 years. This gives a mixed picture for investors assessing recent momentum. Recent headlines around KeyCorp have...
NasdaqGS:CNTA
NasdaqGS:CNTABiotechs

Assessing Centessa Pharmaceuticals (CNTA) Valuation After ORX489 Milestone And Nxera Collaboration Progress

Why Centessa Pharmaceuticals Stock Is Back in Focus Centessa Pharmaceuticals (CNTA) has hit an early development milestone for its investigational orexin receptor 2 agonist, ORX489, tied to neuropsychiatric disorders. This achievement has triggered a US$3 million milestone payment to collaboration partner Nxera Pharma. The payment is set to be recognized as revenue in the first quarter of 2026, giving investors a fresh data point on how this research collaboration feeds into Centessa's...
NasdaqGS:DRH
NasdaqGS:DRHHotel and Resort REITs

Profit Gains, Capital Returns and Board Moves Could Be A Game Changer For DiamondRock Hospitality (DRH)

DiamondRock Hospitality Company recently reported its fourth-quarter and full-year 2025 results, showing higher net income and earnings per share despite slightly lower sales and revenue, while also updating investors on its ongoing share repurchase program and a quarterly dividend of US$0.09 per share payable in April 2026. The combination of improved profitability, continued capital returns through buybacks and dividends, and upcoming board leadership changes adds new context for how...
NYSE:NVO
NYSE:NVOPharmaceuticals

Novo Nordisk Faces Securities Probe And GLP-1 Compounding Crackdown

Law firm launches investigation into NYSE:NVO for potential securities violations following a setback in an obesity drug clinical trial. U.S. regulators issue warning letters to telehealth companies selling compounded GLP-1 drugs that compete with Novo Nordisk’s branded treatments. Developments raise questions about legal exposure for the company and the regulatory environment around GLP-1 weight loss therapies. As a leader in GLP-1 based therapies for diabetes and obesity, NYSE:NVO sits at...
NasdaqGS:RVMD
NasdaqGS:RVMDBiotechs

Revolution Medicines Trials, Funding Capacity And Insider Moves Shape Risk Outlook

Revolution Medicines (NasdaqGS:RVMD) is advancing clinical trials for its RAS(ON) inhibitor pipeline targeting RAS-addicted cancers. The company reported higher R&D spending and wider net losses as it pushes its oncology candidates through the clinic. To reinforce its balance sheet, RVMD filed for a US$1b at-the-market equity program and a US$1.24b shelf registration. Director Mark A. Goldsmith reported significant insider share sales, drawing attention to executive capital...
NYSE:CYD
NYSE:CYDMachinery

Assessing China Yuchai International’s Valuation After Strong 2025 Sales And Earnings Growth

Earnings jump puts China Yuchai International (CYD) in focus China Yuchai International (NYSE:CYD) is back on investor radars after reporting full year 2025 results, with sales of CN¥24,661.77 million and net income of CN¥537.39 million compared to the prior year. See our latest analysis for China Yuchai International. The latest earnings release has arrived after a strong period for investors, with the share price at US$41.30, a 90 day share price return of 18.85% and a 1 year total...
NasdaqGS:AGNC
NasdaqGS:AGNCMortgage REITs

AGNC Investment (AGNC) Valuation Check After Recent Pullback And Conflicting Fair Value Signals

AGNC Investment stock moves and recent performance snapshot AGNC Investment (AGNC) has drawn investor attention after a recent pullback, with the stock closing at US$10.64 and showing mixed total returns across the past week, month, past 3 months and year. See our latest analysis for AGNC Investment. The recent pullback, including a 2.39% one day share price decline and softer 7 day and 30 day share price returns, sits alongside a 12 month total shareholder return of 18.48% and a 3 year total...
NYSE:UDR
NYSE:UDRResidential REITs

A Look At UDR (UDR) Valuation As Fresh Analyst Calls Renew Investor Attention

Recent analyst moves around UDR (UDR), including several rating reiterations and revised views, have put the apartment REIT back on investors’ radar, with opinions split on near term demand but generally constructive on its dividend track record. See our latest analysis for UDR. UDR’s share price has been fairly range bound recently, with a 1 day share price return of 1.11% decline and a 90 day share price return of 5.82% lifting it modestly year to date. However, the 1 year total shareholder...
NYSE:XPEV
NYSE:XPEVAuto

XPeng’s Volkswagen-Backed VLA 2.0 Software Pivot Might Change The Case For Investing In XPEV

XPeng recently reported February 2026 deliveries of 15,256 vehicles and officially launched its second-generation VLA 2.0 autonomous driving system, with Volkswagen as the first external customer. By supplying its VLA 2.0 platform to Volkswagen and preparing robotaxis in Guangzhou, XPeng is positioning itself as an AI software provider beyond its own EV line-up. Next, we’ll examine how XPeng’s Volkswagen-backed VLA 2.0 launch could reshape its investment narrative around software-driven...
NasdaqGM:BAER
NasdaqGM:BAERCommercial Services

Bridger Aerospace (BAER) Q3 Profit Of US$27.6m Tests Narrative Of Persistent Losses

Bridger Aerospace Group Holdings (BAER) has reported a sharp swing in its latest quarter, with Q3 FY 2025 revenue of US$67.9 million and basic EPS of US$0.50, alongside net income of US$27.6 million. The company has seen quarterly revenue move between US$13.0 million and US$67.9 million since Q2 2024, while basic EPS has ranged from a loss of US$0.81 per share on a trailing twelve month basis to a quarterly profit of US$0.50 per share. This gives investors a wide set of earnings outcomes to...
NYSE:PRSU
NYSE:PRSUHospitality

Pursuit Attractions (PRSU) Is Up 6.6% After Record 2025 Sales, Lower Profit And New Guidance

Pursuit Attractions and Hospitality, Inc. reported past full-year 2025 results with revenue rising to US$452.42 million while net income dropped sharply to US$22.67 million, alongside issuing 2026 revenue guidance of about US$465 million and completing a US$10.2 million share repurchase of 305,038 shares. The contrast between record revenue and a very large prior-year net income figure, combined with fresh guidance and buybacks, gives investors more detail on how Pursuit is balancing growth...
NasdaqGS:VSEC
NasdaqGS:VSECAerospace & Defense

VSE (VSEC) Is Down 7.8% After 2025 Results Show Higher Revenue But Softer Net Income

VSE Corporation recently reported full-year 2025 results, with revenue rising to US$1,112.28 million from US$786.26 million a year earlier, while net income eased to US$11.70 million, and the board affirmed a regular quarterly dividend of US$0.10 per share payable on April 29, 2026. Despite lower overall net income, earnings per share from continuing operations increased year on year and management projected consolidated 2026 revenue growth of about 19% to 23%, including contributions from...
NasdaqGS:USLM
NasdaqGS:USLMBasic Materials

Should Insider Selling And Rising Pricing Power Require Action From United States Lime & Minerals (USLM) Investors?

In early March 2026, United States Lime & Minerals reported insider selling by Director Sandra Duhe alongside fresh data highlighting strong operating metrics and a price‑to‑earnings ratio of 32. Investors reacted to the latest ISM Manufacturing report, which pointed to higher input costs but also potential pricing power and margin support for this lime and limestone supplier to construction, environmental, and industrial markets. With the stock posting a 2.88% seven‑day return despite a...
NasdaqGS:PENN
NasdaqGS:PENNHospitality

PENN Entertainment (PENN) Valuation Check After Earnings Beat Activist Agreement And Digital Growth Targets

PENN Entertainment (PENN) is back in focus after its latest quarterly results, where management highlighted strong digital performance, a path to digital breakeven by 2026, and fresh board appointments tied to activist investor HG Vora. See our latest analysis for PENN Entertainment. Despite the recent earnings beat and governance changes, PENN Entertainment’s latest share price of US$14.64 comes after a 12.27% 1 month share price return, but a 19.91% decline in 1 year total shareholder...
NasdaqGS:ASTS
NasdaqGS:ASTSTelecom

Assessing AST SpaceMobile (ASTS) Valuation After TELUS Partnership And Growing Contracted Revenue Commitments

AST SpaceMobile (ASTS) has jumped back into the spotlight after TELUS Corporation agreed to use its satellites for space based cellular broadband across Canada and to take an equity stake in the company. See our latest analysis for AST SpaceMobile. The TELUS deal caps an eventful stretch for AST SpaceMobile, with recent earnings showing it is now generating revenue, fresh contracts such as the US$30 million SDA Europa Track 2 award, and new index inclusion in the Bloomberg 500. Despite...
NYSE:VST
NYSE:VSTRenewable Energy

Vistra (VST) Expands Battery Rewards Program Amid Earnings Volatility – What Does It Signal About Storage Visibility?

Vistra Corp. recently reported full-year 2025 results, with sales of US$17,738 million versus US$17,224 million a year earlier and net income of US$944 million versus US$2,659 million, while also expanding its Battery Rewards program in Texas by integrating Enphase Energy’s IQ Batteries to support grid reliability. At the same time, analysts’ earnings expectations have moved higher even as some investors question the company’s limited disclosure on long-term power purchase agreements and its...
NYSE:PG
NYSE:PGHousehold Products

Court Keeps P&G ZzzQuil Labeling Suit Alive Raising Brand Questions

A federal court has ruled that Procter & Gamble (NYSE:PG) must face a lawsuit over the labeling of its ZzzQuil Pure Zzzs melatonin products. The suit alleges that the product labels may mislead consumers about how natural the ingredients are. The court decision keeps the case alive and raises questions about labeling practices across over the counter sleep aids. For a company like Procter & Gamble, which depends heavily on trust in everyday consumer brands, challenges around product...
NYSE:CCL
NYSE:CCLHospitality

Carnival Faces Security Shocks And Fuel Pressures Testing Cruise Earnings

Carnival Corporation & (NYSE:CCL) has canceled all Puerto Vallarta port calls across its brands because of cartel related violence and safety concerns. The company is also contending with disruptions tied to Middle East conflict, affecting cruise routes and operational planning. Higher fuel costs linked to regional tensions are adding pressure to operating expenses and itinerary decisions. Carnival Corporation & is dealing with these operational shocks while its share price sits at $25.79...